<img src="https://trc.taboola.com/1321591/log/3/unip?en=page_view" width="0" height="0" style="display:none">
Fact Check Library

Fact Check with Logically.

Download the Free App Today

true
true

CLAIM ID

2690ea16

Banning Trump from Twitter has resulted in Twitter's shares going down by 1.8%.

Twitter shares fell after banning Trump from its platform despite other tech stocks closing on a positive note.

Twitter shares fell after banning Trump from its platform despite other tech stocks closing on a positive note.US President Donald Trump was recently barred from social media platforms like Twitter, Facebook, and Instagram. The move came in following his supporters ravaging Capitol Hill, which many blamed on Trump's rhetoric of inciting violence. Twitter locked the account of President Trump and even threatened to ban him from the platform permanently. Facebook, on the other hand, restricted Trump from posting for at least 2 weeks.

Just after this, Twitter shares slipped 1.8% by the closing bell even though tech stocks closed on a high. Facebook gained 2% in line with the indices.

As per the data published by the Wallstreet Journal, Trump has 88.7 million followers on Twitter, which constituted 48% of the company’s total base of monetizable daily active users. In contrast, his Facebook account is followed by about 35 million followers—less than 2% of the company’s 1.8 billion daily active users. Trump gets a lot of attention for using Twitter and has a huge impact on the Twitter platform. He had used it to spread his narrative even before he became the president. So it makes sense that Twitter shares were down during the trading session.

Have a question or correction on one of our fact-checks?

If you think a claim has been misjudged or requires correction, please send us evidence to support your error claim. We will revisit our evidence and verdict and conduct additional research to verify new information.

Fact Check of the Day

misleading

397 children were diagnosed with heart inflammation after receiving Pfizer’s COVID-19 vaccine in U.S.